Upcoming Webinars

https://biopharmawebinars.com/webinars/fatty-acid-extractables-leachables-profiles-as-an-indicator-of-technical-grade-stearate-acid-additive-origin/

Fatty Acid Extractables/Leachables Profiles as an Indicator of Technical Grade Stearate Acid Additive Origin

Presented by Daniel Norwood, Principal Consultant at Feinberg Norwood & Associates Pharma Consulting
18th February 2026

https://biopharmawebinars.com/webinars/mrna-products-an-overview-on-strategy-for-potency-for-ds-vs-dp/

mRNA Products: An Overview on Strategy for Potency for DS vs DP

Presented by Khaled Yamout, Analytical Sciences, Quality and Manufacturing Consultant, Yamout Chem Consulting, LLC
24th February 2026

https://biopharmawebinars.com/webinars/developing-a-site-wide-contamination-control-strategy-from-risk-mapping-to-implementation/

Developing a Site-Wide Contamination Control Strategy: From Risk Mapping to Implementation

Presented by Joseph Horvath, PhD, Head of Quality Risk Management at Takeda Pharmaceuticals, Liz Brockson, Aseptic Processing and Sterility Assurance Lead in Global Sterility Assurance and Microbiology at Takeda
02nd March 2026

https://biopharmawebinars.com/webinars/assessing-the-use-of-solid-phase-cytometry-for-rapid-bioburden-testing-2/

Assessing the Use of Solid-Phase Cytometry for Rapid Bioburden Testing

Presented by Sophie Drinkwater, Associate Director in Microbiology at AstraZeneca
03rd March 2026

 

On Demand Webinars

https://biopharmawebinars.com/webinars/enabling-broader-adoption-of-mam-comparison-of-mam-vs-conventional-methods/

Enabling Broader Adoption of MAM: Comparison of MAM vs. Conventional Methods

Presented by Diane McCarthy, Senior Director, Science and Standards, Global Biologics Department at US Pharmacopeia, Andrew W. Dawdy, Ph.D. Senior Principal Scientist at Pfizer, Michelle English, Ph.D., Scientific Consultant at Genedata, Ying Qing Yu, PhD, Director of the Biopharmaceutical Applications Team at Waters Corporation
05th February 2026

https://biopharmawebinars.com/webinars/n-nitrosamines-past-present-and-future-through-the-eyes-of-an-analytical-chemist/

N-Nitrosamines – Past, Present and Future Through the Eyes of an Analytical Chemist

Presented by Andrew Teasdale, Principal Consultant Nelson Labs
03rd February 2026

https://biopharmawebinars.com/webinars/overview-and-future-plans-of-the-usp-rapid-microbiological-methods-subcommittee/

Overview and Future Plans of the USP Rapid Microbiological Methods Subcommittee

Presented by Dr David Roesti, PhD. Microbiologist/Facilitator QA/QC at Novartis Pharma AG and Jon Kallay, Senior Technical & Market Development Manager at Charles River Laboratories
29th January 2026

https://biopharmawebinars.com/webinars/developing-and-deploying-digital-ai-solutions-in-pharma-the-reality-vs-the-hype/

Developing and Deploying Digital & AI Solutions in Pharma: The Reality vs. the Hype

Presented by Saly Romero-Torres, Ph.D. Owner, Hyperplane LLC, Dan Hill, Director, Process Analytics at Fujufilm Biotechnologies, Paul Gillham, Innovations Director, SciY, Ashley Howard, Sr. Director, Product Management A&D at Cytiva and Dr. Alessandro Butté, CEO DataHow
21st January 2026